Anavex Life Sciences Corp.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 278 | 0.0% | 78,005 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 697 | 0.0% | 78,355 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 722 | 0.0% | 78,352 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 672 | 0.0% | 78,352 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 59 | 0.0% | 5,493 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 31 | 0.0% | 5,493 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 22 | 0.0% | 5,275 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 413 | 0.0% | 81,052 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 790 | 0.0% | 84,885 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 571 | 0.0% | 87,169 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 759 | 0.0% | 93,394 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 807 | 0.0% | 94,198 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 883 | 0.0% | 95,314 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 969 | 0.0% | 93,916 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 940 | 0.0% | 93,927 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 1,119 | 0.0% | 90,900 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 1,690 | 0.0% | 97,445 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 1,604 | 0.0% | 89,373 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 1,956 | 0.0% | 85,577 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 1,317 | 0.0% | 88,082 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 427 | 0.0% | 79,027 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 360 | 0.0% | 79,027 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 369 | 0.0% | 74,907 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 236 | 0.0% | 74,907 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 171 | 0.0% | 66,095 | 12/31/2019 |